"As part of the comprehensive spinal cord treatment services offered by the Spine Hospital at Mount Sinai, the Spine Center is a dedicated space within the hospital. The Spine Center is fully staffed with unparalleled experts—orthopedists, chiropractors, physiatrists, occupational therapists, physical therapists, social workers, nurse managers, and spine surgeons—each specializing in the care of patients receiving treatment for spinal disorders, including lumbar, cervical, spinal deformity, spine trauma, and athletic spine injuries."

During the past decade, Mount Sinai PRIME conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai PRIME" #1 collaborator was "Gynecologic Oncology Group" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai PRIME" are "Allogeneic Hematopoietic Stem Cell Transplantation" (1 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Colitis, Ulcerative" (1 trials), "Fallopian Tube Adenocarcinoma" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Mount Sinai PRIME" in a lesser frequency.

Most popular intervention types in "Mount Sinai PRIME" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vedolizumab" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials), "Azilsartan Medoxomil High-dose" (1 trials) and "Azilsartan Medoxomil Low-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai PRIME" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mount Sinai PRIME". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mount Sinai PRIME, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai PRIME, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".